hidden hidden hidden hidden hidden hidden hidden hidden
Oxford location
view map

Edmund Cartwright House, 4 Robert Robinson Avenue
Oxford Science Park, Oxford, OX4 4GA, UK

Tel: +44 (0)845 034 7900 | Fax: +44 (0)845 034 7901

Cambridge location
view map

Suite 4, The Mansion, Chesterford Research Park
Little Chesterford, Essex, CB10 1XL, UK

Tel: +44 (0)845 034 7900 | Fax: +44 (0)845 034 7901

Contact us

If you have any enquires or questions, feel free to get in touch with Oxford Nanopore.

Follow us on Twitter
Apply to the MAP

The MinION™ Access Programme (MAP) is a community-focused access project which started in Spring 2014. The philosophy of the MAP is to enable a broad range of people to explore how the MinION may be useful to them, to contribute to developments in analytical tools and applications and to share their experiences and collaborate. Listening to this community helps Oxford Nanopore provide continuous improvements to our products and support. To apply to join the MAP click here.

Executive - Zoe McDougall
Zoe McDougall
Corporate and Communications Director

Zoe has extensive experience in marketing, corporate and investor communications in the science and healthcare sector. Zoe joined Oxford Nanopore in January 2008, bringing expertise in pre-marketing of products, building and management of corporate reputation, IR and fundraising.  At Oxford Nanopore Zoe works with the executive and management teams to ensure that the business development plan is supported by strategic serving of investor, customer and other stakeholder relationships. She also works on the fundraisings that have so far raised £74 million.

Zoe gained a BSc in Physiology, specialising in electrophysiology and neurophysiology, at the University of Bristol. The first years of her career were spent with SmithKline Beecham, working in sales and marketing. Zoe then joined Porter Novelli, where she consulted on marketing communications and issues management for companies including Glaxo Wellcome, Novartis and Bristol-Myers Squibb and conducted award-winning work on the blood products/ nvCJD issue for BPL, part of the National Blood Service.

At specialty pharmaceutical company Sinclair Pharmaceuticals, Zoe played an integral role in the £60m IPO and headed subsequent corporate and investor communications. In 2005, Zoe worked with a Sri Lankan humanitarian organization to create and manage a mobile medical unit, serving populations displaced by the Asian tsunami and civil unrest